Execution instability often originates in strategy timing rather than study conduct, which sponsors can correct by ...

In this video interview, Hal Green, senior solution architect and life sciences vertical lead EMEA at Loftware, discusses why ...

In this video interview, Hal Green, senior solution architect and life sciences vertical lead EMEA at Loftware, explains how growing trial complexity has shifted the fundamental supply chain question ...

In this video interview, Hal Green, senior solution architect and life sciences vertical lead EMEA at Loftware, traces how ...

In this video interview, Mark Freitas, managing director and life sciences practice lead at Alvarez & Marsal, offers a ...

A prespecified interim analysis showed statistically significant PFS improvement with elranatamab versus ...

FDA-regulator access to near real-time safety and endpoint streams is intended to enable earlier signal detection and more ...

As the use of digital tools continues to expand within clinical research, effective data management for eCOA systems is more important than ever. From initial design and system setup to ongoing ...

A newly published Cochrane systematic review examining amyloid-beta-targeting monoclonal antibodies in Alzheimer's disease ...

In today’s ACT Brief, we highlight where AI is delivering real gains in protocol development, how geopolitical disruption is ...

Sites can strengthen their position by approaching feasibility strategically, investing in clear communication, and being ...

In this case study, discover how Parexel takes on the most operationally complex prostate cancer trials — delivering with confidence, speed, and control to de-risk pivotal programs, accelerate ...